Authors

• Yusuf Ali (ORCID: https://orcid.org/0000-0002-0681-1125)
• Guy A. Rutter (ORCID: https://orcid.org/0000-0001-6360-0343)
• Harish Babu (ORCID: https://orcid.org/0000-0001-8985-7526)
• Bernett Teck Kwong Lee (ORCID: https://orcid.org/0000-0002-2709-1972)
• Daniel K. Y. Tan (ORCID: https://orcid.org/0000-0003-0449-4557)
• Qing Wei Calvin Ho (ORCID: https://orcid.org/0000-0001-6281-7399)
• Dewei Kong
• Rosi Chelliah
• Surabhi Devaraj (ORCID: https://orcid.org/0000-0002-6224-9376)
• Adrian Kee Keong Teo (ORCID: https://orcid.org/0000-0001-5901-7075)
• Xiaoling Wang
• Divya Gunaseelan (ORCID: https://orcid.org/0009-0000-1515-7332)
• James A. Miller
• Vanessa Shiyun Tay
• Xin Yan Chew

Institutions

• Agency for Science, Technology and Research (SG)
• National University of Singapore (SG)
• Nanyang Technological University (SG)
• McGill University Health Centre (CA)
• Khoo Teck Puat Hospital (SG)
• Precision for Medicine (United States) (US)
• Imperial College London (GB)
• All India Institute of Medical Sciences (IN)
• Université de Montréal (CA)
• Institute of Molecular and Cell Biology (SG)

Publication Details

Journal

Diabetologia

Published

2025-09-26

DOI

https://doi.org/10.1007/s00125-025-06541-0

Primary Topic

Protein Degradation and Inhibitors

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Wellcome Trust
• Diabetes UK
• National Research Foundation
• Nanyang Technological University
• Lunds Universitet
• Ministry of Education, India
• National Institutes of Health
• Canadian Institutes of Health Research
• Medical Research Council
• Institute of Molecular and Cell Biology
• Lee Kong Chian School of Medicine, Nanyang Technological University
• National Institute of Diabetes and Digestive and Kidney Diseases